share_log

ProSomnus | 8-K: Current report

ProSomnus | 8-K: Current report

ProSomnus | 8-K:重大事件
SEC announcement ·  03/22 16:18
Moomoo AI 已提取核心訊息
ProSomnus, Inc., a company listed on the Nasdaq Global Market under the trading symbol OSA, has reported a failure to comply with Nasdaq's minimum Market Value of Publicly Held Shares (MVPHS) requirement of $15 million as of the compliance deadline on March 18, 2024. The company received a determination letter from Nasdaq on March 19, 2024, confirming its non-compliance. ProSomnus had previously disclosed its non-compliance and its intention to appeal the delisting determination related to the Market Value of Listed Securities (MVLS) requirement. A hearing with the Nasdaq Hearings Panel has been scheduled, where ProSomnus plans to present a compliance plan addressing both the MVPHS and MVLS requirements. The company also faces non-compliance with Nasdaq's minimum bid price requirement, with...Show More
ProSomnus, Inc., a company listed on the Nasdaq Global Market under the trading symbol OSA, has reported a failure to comply with Nasdaq's minimum Market Value of Publicly Held Shares (MVPHS) requirement of $15 million as of the compliance deadline on March 18, 2024. The company received a determination letter from Nasdaq on March 19, 2024, confirming its non-compliance. ProSomnus had previously disclosed its non-compliance and its intention to appeal the delisting determination related to the Market Value of Listed Securities (MVLS) requirement. A hearing with the Nasdaq Hearings Panel has been scheduled, where ProSomnus plans to present a compliance plan addressing both the MVPHS and MVLS requirements. The company also faces non-compliance with Nasdaq's minimum bid price requirement, with a compliance period ending on April 30, 2024. ProSomnus has stated that there is no assurance that the Panel will accept its compliance plan or that the company will be able to regain compliance with Nasdaq's listing requirements. The potential delisting of ProSomnus' securities could negatively impact the ability to trade its securities, obtain accurate quotations, and could materially affect the securities' price. It may also hinder the company's ability to raise capital and trigger defaults under existing agreements.
ProSomnus, Inc. 是一家在納斯達克全球市場上市的公司,交易代碼爲OSA,該公司報告稱,截至2024年3月18日的合規截止日期,該公司未能遵守納斯達克公開持股最低市值(MVPHS)的1500萬美元要求。該公司於2024年3月19日收到了納斯達克的裁決書,證實了其違規行爲。ProsomNUS此前曾披露其違規行爲,並打算對與上市證券市值(MVLS)要求相關的退市決定提出上訴。已計劃與納斯達克聽證會小組舉行聽證會,ProsomNUS計劃在聽證會上提出一項滿足MVPHS和MVLS要求的合規計劃。該公司還面臨不遵守納斯達克最低出價要求的問題,合規期將於2024年4月30日結束。ProsomN...展開全部
ProSomnus, Inc. 是一家在納斯達克全球市場上市的公司,交易代碼爲OSA,該公司報告稱,截至2024年3月18日的合規截止日期,該公司未能遵守納斯達克公開持股最低市值(MVPHS)的1500萬美元要求。該公司於2024年3月19日收到了納斯達克的裁決書,證實了其違規行爲。ProsomNUS此前曾披露其違規行爲,並打算對與上市證券市值(MVLS)要求相關的退市決定提出上訴。已計劃與納斯達克聽證會小組舉行聽證會,ProsomNUS計劃在聽證會上提出一項滿足MVPHS和MVLS要求的合規計劃。該公司還面臨不遵守納斯達克最低出價要求的問題,合規期將於2024年4月30日結束。ProsomNus表示,無法保證專家小組會接受其合規計劃,也無法保證該公司能夠重新遵守納斯達克的上市要求。ProsomNUS證券的潛在退市可能會對其證券交易、獲得準確報價的能力產生負面影響,並可能對證券價格產生重大影響。它還可能阻礙公司根據現有協議籌集資金和觸發違約的能力。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息